Results 21 to 30 of about 63,209 (242)
Lung India, 2019 Autoimmune pulmonary alveolar proteinosis (PAP) is a rare lung disease. Although recombinant human granulocyte macrophage colony-stimulating factor (GM-CSF) therapy has emerged as a new therapeutic modality, whole-lung lavage (WLL) with manual chest ...
Kei Nakamura +3 more
doaj +2 more sources
Self-assembling nanoparticles containing dexamethasone as a novel therapy in allergic airways inflammation. [PDF]
, 2013 Nanocarriers can deliver a wide variety of drugs, target them to sites of interest, and protect them from degradation and inactivation by the body. They have the capacity to improve drug action and decrease undesirable systemic effects.
Bratt, Jennifer M +6 more
core +9 more sources
The effect of acute ventilation-perfusion mismatch on respiratory heat exchange in a porcine model.
PLoS ONE, 2021 BackgroundRespiratory heat exchange is an important physiological process occurring in the upper and lower respiratory tract and is usually completed when inspired gases reach the alveoli.
Maximilian Edlinger-Stanger +10 more
doaj +1 more source
Respiratory Medicine Case Reports, 2022 Pulmonary alveolar proteinosis (PAP) is a diffuse lung disease characterized by the accumulation of alveolar surfactants due to dysfunction of granulocyte-macrophage colony-stimulating factor-dependent cholesterol clearance.
Tomotsugu Takano +5 more
doaj +1 more source
Frontiers in Medicine, 2023 The diagnosis of pulmonary alveolar proteinosis (PAP) is based on biopsies. Compared with other methods of taking biopsies, transbronchial lung cryobiopsy (TBLC) has a higher diagnostic rate and the likelihood of pneumothorax.
Hua-Man Wu +3 more
doaj +1 more source
Whole lung lavage for lipoid pneumonia [PDF]
Thorax, 2016 We evaluated a 49-year-old woman who had worsening shortness of breath, non-productive cough and recurrent low-grade fevers over 6 months despite several courses of antibiotics. Her medical history was remarkable for suspected immunodeficiency that had been treated with intravenous immunoglobulin and recurrent pneumonia, including methicillin-resistant
Chris, Lau +3 more
openaire +2 more sources
COVID-19 and severe pulmonary alveolar proteinosis (PAP): A case report
Heliyon, 2023 Background: Pulmonary alveolar proteinosis (PAP) is a rare lung disease that mainly presents with dyspnea. PAP diagnosis can be easily missed in the background of a coronavirus disease 2019 (COVID-19) infection, due to the similarity of their ...
Ahmad Basim Melhem +4 more
doaj +1 more source
Mutation in methionyl-tRNA synthetase 1 causing pulmonary alveolar proteinosis
Indian Pediatrics Case Reports, 2023 Background: A chronic history of exertional dyspnea, dry cough, and fatigue, associated with reticulonodular ground-glass opacity indicates an underlying interstitial lung disease (ILD).
Manoj Madhusudan +2 more
doaj +1 more source
Anesthetic management of bilateral pulmonary alveolar proteinosis for whole lung lavage
The Indian Anaesthetists' Forum, 2020 Pulmonary alveolar proteinosis (PAP) is a rare lung diseases in which there is abnormal accumulation of lung surfactant in alveoli by lipoproteinaceous material. The standard method for management of such cases is whole lung lavage (WLL). We report a PAP
Nilesh M Solanki +2 more
doaj +1 more source
Rituximab Therapy in Pulmonary Alveolar Proteinosis: A Rare Case Report [PDF]
Journal of Clinical and Diagnostic Research, 2018 Pulmonary Alveolar Proteinosis (PAP) is a rare disorder characterised by accumulation of surfactant in alveoli due to impaired surfactant clearance. Although, whole lung lavage is the standard treatment of PAP, rituximab has also been introduced as a ...
Fatemeh Aghaei Meybodi +3 more
doaj +1 more source